In this sense, our group previously found that non-anti-TNF bDMARDs were associated with reduced progression of lung disease in patients with RA-ILD in the short term in a prospective cohort of 70 patients [33], although we observed that despite the increase in follow-up time and number of patients included, this association remains unchanged. Here, TNF is linked to interstitial lung disease.